alpha-benzyl-n-methylphenethylamine has been researched along with Seizures in 1 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Compton, DR; Mirshahi, T; Moore, KA; Poklis, A; Woodward, JJ | 1 |
1 other study(ies) available for alpha-benzyl-n-methylphenethylamine and Seizures
| Article | Year |
|---|---|
Pharmacological characterization of BNMPA (alpha-benzyl-N-methylphenethylamine), an impurity of illicit methamphetamine synthesis.
Topics: Analysis of Variance; Animals; Brain; Carrier Proteins; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; In Vitro Techniques; Male; Membranes; Methamphetamine; Mice; Paroxetine; Rats; Rats, Sprague-Dawley; Seizures; Selective Serotonin Reuptake Inhibitors | 1996 |